Blau syndrome: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 9: Line 9:
'''Blau syndrome''' is characterized by familial granulomatous arthritis, iritis, and skin granulomas, comprising an [[autosomal dominant|autosomal dominantly]] inherited syndrome that overlaps both sarcoidosis and granuloma annulare.<ref name="Fitz2">Freedberg, et. al. (2003). ''Fitzpatrick's Dermatology in General Medicine''. (6th ed.). McGraw-Hill. ISBN 0071380760.</ref>{{rp|983}}<ref name="Andrews">James, William; Berger, Timothy; Elston, Dirk (2005). ''Andrews' Diseases of the Skin: Clinical Dermatology''. (10th ed.). Saunders. ISBN 0721629210.</ref>{{rp|149}}  Restated, Blau syndrome is a rare autosomal dominant disorder characterized by granulomatous polyarthritis, panuveitis, cranial neuropathies and exanthema.<ref name="pmid17223962">{{cite journal |author=Ferrero-Miliani L, Nielsen OH, Andersen PS, Girardin SE |title=Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation |journal=Clin. Exp. Immunol. |volume=147 |issue=2 |pages=227–35 |year=2007 |month=February |pmid=17223962 |pmc=1810472 |doi=10.1111/j.1365-2249.2006.03261.x |url=}}</ref>{{rp|232}}
'''Blau syndrome''' is characterized by familial granulomatous arthritis, iritis, and skin granulomas, comprising an [[autosomal dominant|autosomal dominantly]] inherited syndrome that overlaps both sarcoidosis and granuloma annulare.<ref name="Fitz2">Freedberg, et. al. (2003). ''Fitzpatrick's Dermatology in General Medicine''. (6th ed.). McGraw-Hill. ISBN 0071380760.</ref>{{rp|983}}<ref name="Andrews">James, William; Berger, Timothy; Elston, Dirk (2005). ''Andrews' Diseases of the Skin: Clinical Dermatology''. (10th ed.). Saunders. ISBN 0721629210.</ref>{{rp|149}}  Restated, Blau syndrome is a rare autosomal dominant disorder characterized by granulomatous polyarthritis, panuveitis, cranial neuropathies and exanthema.<ref name="pmid17223962">{{cite journal |author=Ferrero-Miliani L, Nielsen OH, Andersen PS, Girardin SE |title=Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation |journal=Clin. Exp. Immunol. |volume=147 |issue=2 |pages=227–35 |year=2007 |month=February |pmid=17223962 |pmc=1810472 |doi=10.1111/j.1365-2249.2006.03261.x |url=}}</ref>{{rp|232}}
==Historical Perspective==
==Historical Perspective==
*Blau syndrome was first discovered by Dr. Edward B. Blau, in 1985 following observation of a four-generation family with a variety of symptoms including granulomatous arthritis, iritis, and skin rash.<ref name="Blau1985">{{cite journal|last1=Blau|first1=Edward B.|title=Familial granulomatous arthritis, iritis, and rash|journal=The Journal of Pediatrics|volume=107|issue=5|year=1985|pages=689–693|issn=00223476|doi=10.1016/S0022-3476(85)80394-2}}</ref>
*Blau syndrome was first discovered by Dr. Edward B. Blau, in 1985 following observation of a four-generation family with a variety of [[symptoms]] including [[granulomatous]] [[arthritis]], [[iritis]], and [[skin rash]].<ref name="Blau1985">{{cite journal|last1=Blau|first1=Edward B.|title=Familial granulomatous arthritis, iritis, and rash|journal=The Journal of Pediatrics|volume=107|issue=5|year=1985|pages=689–693|issn=00223476|doi=10.1016/S0022-3476(85)80394-2}}</ref>
*Jabs Syndrome was introduced in the same year (1985) by Dr. A. Douglas Jabs following visiting patients with polyarthritis, uveitis, and cranial neuropathy.<ref name="JabsHouk1985">{{cite journal|last1=Jabs|first1=Douglas A.|last2=Houk|first2=J.Lawrence|last3=Bias|first3=Wilma B.|last4=Arnett|first4=Frank C.|title=Familial granulomatous synovitis, uveitis, and cranial neuropathies|journal=The American Journal of Medicine|volume=78|issue=5|year=1985|pages=801–804|issn=00029343|doi=10.1016/0002-9343(85)90286-4}}</ref>
*Jabs Syndrome was introduced in the same year (1985) by Dr. A. Douglas Jabs following visiting patients with [[polyarthritis]], [[uveitis]], and [[cranial neuropathy]].<ref name="JabsHouk1985">{{cite journal|last1=Jabs|first1=Douglas A.|last2=Houk|first2=J.Lawrence|last3=Bias|first3=Wilma B.|last4=Arnett|first4=Frank C.|title=Familial granulomatous synovitis, uveitis, and cranial neuropathies|journal=The American Journal of Medicine|volume=78|issue=5|year=1985|pages=801–804|issn=00029343|doi=10.1016/0002-9343(85)90286-4}}</ref>
*In 19??, NOD2 mutations were first implicated in the pathogenesis of Blau syndrome.
*In 19??, NOD2 mutations were first implicated in the [[pathogenesis]] of Blau syndrome.


==Classification==
==Classification==
*There is no established system for the classification of Blau syndrome.
*There is no established system for the [[classification]] of Blau syndrome.
==Pathophysiology==
==Pathophysiology==
*The exact pathogenesis of Blau syndrome is not fully understood. However, it is caused by a mutation in the NOD2 gene.
*The exact [[pathogenesis]] of Blau syndrome is not fully understood. However, it is caused by a [[mutation]] in the [[NOD2]] [[gene]].
*The disease is inherited in an autosomal dominant mode.
*The [[disease]] is inherited in an [[autosomal dominant]] mode.
*This gene encodes a protein called xxxx, involving in the ....
*This gene encodes a protein called xxxx, involving in the ....
*NOD2 mutation leads to overactivation of xxxxx which may trigger an exaggerated inflammatory response.  
*NOD2 mutation leads to overactivation of xxxxx which may trigger an exaggerated inflammatory response.  
Line 23: Line 23:
*Blau syndrome may be caused by a mutation in the NOD2 gene.  
*Blau syndrome may be caused by a mutation in the NOD2 gene.  
==Differentiating Blau syndrome from Other Diseases==
==Differentiating Blau syndrome from Other Diseases==
*Blau syndrome must be differentiated from other diseases that cause arthritis, skin rash, and ophthalmologic involvement, such as Neonatal onset multisystem inflammatory disease (NOMID), cryopyrin-associated periodic syndrome (CAPS), and familial mediterranean fever.
*Blau syndrome must be differentiated from other [[diseases]] that cause [[arthritis]], [[skin rash]], and [[ophthalmological]] involvement, such as Neonatal onset multisystem inflammatory disease (NOMID), [[cryopyrin-associated periodic syndrome]] ([[CAPS]]), and [[familial mediterranean fever]].
*For more information please click here.
*For more information please click here.
==Epidemiology and Demographics==
==Epidemiology and Demographics==
*There is no available data on the prevalence and incidence of Blau syndrome.
*There is no available data on the [[prevalence]] and [[incidence]] of Blau syndrome.
*Blau syndrome commonly affects individuals younger than 4 years of age.
*Blau syndrome commonly affects individuals younger than 4 years of age.
*There is no racial predilection to Blau syndrome.
*There is no [[racial]] predilection to Blau syndrome.
*Blau syndrome affects men and women equally.
*Blau syndrome affects men and women equally.
==Risk Factors==
==Risk Factors==
*There are no established risk factors for Blau syndrome.
*There are no established [[risk factors]] for Blau syndrome.
==Screening==
==Screening==
There is insufficient evidence to recommend routine screening for Blau syndrome.
There is insufficient evidence to recommend routine [[screening]] for Blau syndrome.
==Natural History, Complications, and Prognosis==
==Natural History, Complications, and Prognosis==
*If left untreated, patients with Blau syndrome may progress to develop blindness, vasculitis, and joint deformities.
*If left untreated, patients with Blau syndrome may progress to develop [[blindness]], [[vasculitis]], and [[joint]] [[deformities]].
*Other possible complications include:
*Other possible [[complications]] include:
**Arterial hypertension
**[[Arterial hypertension]]
**Pulmonary embolism
**[[Pulmonary embolism]]
**
**
*Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
*Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Line 57: Line 57:
There are no established criteria for the diagnosis of Blau syndrome.
There are no established criteria for the diagnosis of Blau syndrome.
===History and Symptoms===
===History and Symptoms===
*Blau syndrome first presents with a scaly rash often by 4 months of age. Fever, arthritis, abdominal pain, and other symptoms may present later by 4 years of age.<ref name="RoséAróstegui2009">{{cite journal|last1=Rosé|first1=Carlos D.|last2=Aróstegui|first2=Juan I.|last3=Martin|first3=Tammy M.|last4=Espada|first4=Graciela|last5=Scalzi|first5=Lisabeth|last6=Yagüe|first6=Jordi|last7=Rosenbaum|first7=James T.|last8=Modesto|first8=Consuelo|last9=Cristina Arnal|first9=Maria|last10=Merino|first10=Rosa|last11=García-Consuegra|first11=Julia|last12=Carballo Silva|first12=María Antonia|last13=Wouters|first13=Carine H.|title=NOD2-Associated pediatric granulomatous arthritis, an expanding phenotype: Study of an international registry and a national cohort in spain|journal=Arthritis & Rheumatism|volume=60|issue=6|year=2009|pages=1797–1803|issn=00043591|doi=10.1002/art.24533}}</ref>
*Blau syndrome first presents with a scaly [[rash]] often by 4 months of age. [[Fever]], [[arthritis]], [[abdominal pain]], and other [[Symptom|symptoms]] may present later by 4 years of age.<ref name="RoséAróstegui2009">{{cite journal|last1=Rosé|first1=Carlos D.|last2=Aróstegui|first2=Juan I.|last3=Martin|first3=Tammy M.|last4=Espada|first4=Graciela|last5=Scalzi|first5=Lisabeth|last6=Yagüe|first6=Jordi|last7=Rosenbaum|first7=James T.|last8=Modesto|first8=Consuelo|last9=Cristina Arnal|first9=Maria|last10=Merino|first10=Rosa|last11=García-Consuegra|first11=Julia|last12=Carballo Silva|first12=María Antonia|last13=Wouters|first13=Carine H.|title=NOD2-Associated pediatric granulomatous arthritis, an expanding phenotype: Study of an international registry and a national cohort in spain|journal=Arthritis & Rheumatism|volume=60|issue=6|year=2009|pages=1797–1803|issn=00043591|doi=10.1002/art.24533}}</ref>
*Rash spread follows a cephalocaudal order. It first appears on the face and then affects the trunk.  
*[[Rash]] spread follows a cephalocaudal order. It first appears on the face and then affects the [[trunk]].
*Arthritis usually affects wrists, knees, and ankles and tends to be symmetrical and chronic.
*[[Arthritis]] usually affects [[Wrist|wrists]], [[knees]], and [[Ankle|ankles]] and tends to be symmetrical and [[chronic]].
===Physical Examination===
===Physical Examination===
{| align="right"
{| align="right"
|[[File:Blau syndrome.jpg|thumb|none|300px|Multiple, reddish-brown papules coalescing over the right arm in a boy with Blau syndrome, Image courtesy of Donald A Glass II MD, PhD, Jennifer Maender MD, Denise Metry M]]
|[[File:Blau syndrome.jpg|thumb|none|300px|Multiple, reddish-brown papules coalescing over the right arm in a boy with Blau syndrome, Image courtesy of Donald A Glass II MD, PhD, Jennifer Maender MD, Denise Metry M]]
|}
|}
*Common physical examination findings of Blau syndrome include fever, scaly rash, and arthritis.
*Common physical examination findings of Blau syndrome include [[fever]], scaly [[rash]], and [[arthritis]].
*Other possible findings include:
*Other possible findings include:
**Cranial nerve involvement
**[[Cranial nerve]] involvement
**Lymphadenopathy
**[[Lymphadenopathy]]
**Hepatosplenomegaly
**[[Hepatosplenomegaly]]
**Uveitis
**[[Uveitis]]
**Conjunctivitis
**[[Conjunctivitis]]
 
===Laboratory Findings===
===Laboratory Findings===
*An elevated concentration of serum acute phase reactants is diagnostic of Blau syndrome.
*An elevated [[concentration]] of serum [[Acute phase reactant|acute phase reactants]] is [[diagnostic]] of Blau syndrome.
===Electrocardiogram===
===Electrocardiogram===
*There are no ECG findings associated with Blau syndrome.
*There are no [[ECG]] findings associated with Blau syndrome.
===X-ray===
===X-ray===
*There are no x-ray findings associated with Blau syndrome.
*There are no [[x-ray]] findings associated with Blau syndrome.
===Echocardiography or Ultrasound===
===Echocardiography or Ultrasound===
*There are no echocardiography/ultrasound findings associated with Blau syndrome.
*There are no [[echocardiography]]/[[ultrasound]] findings associated with Blau syndrome.
===CT scan===
===CT scan===
*There are no CT scan findings associated with Blau syndrome.
*There are no [[CT scan]] findings associated with Blau syndrome.
===MRI===
===MRI===
*There are no MRI findings associated with Blau syndrome.
*There are no [[MRI]] findings associated with Blau syndrome.
===Other Imaging Findings===
===Other Imaging Findings===
*There are no other imaging findings associated with Blau syndrome.
*There are no other [[imaging]] findings associated with Blau syndrome.
===Other Diagnostic Studies===
===Other Diagnostic Studies===
*There are no other diagnostic studies associated with Blau syndrome.
*There are no other [[diagnostic]] studies associated with Blau syndrome.
==Treatment==
==Treatment==
===Medical Therapy===
===Medical Therapy===

Revision as of 16:48, 22 July 2019

WikiDoc Resources for Blau syndrome

Articles

Most recent articles on Blau syndrome

Most cited articles on Blau syndrome

Review articles on Blau syndrome

Articles on Blau syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Blau syndrome

Images of Blau syndrome

Photos of Blau syndrome

Podcasts & MP3s on Blau syndrome

Videos on Blau syndrome

Evidence Based Medicine

Cochrane Collaboration on Blau syndrome

Bandolier on Blau syndrome

TRIP on Blau syndrome

Clinical Trials

Ongoing Trials on Blau syndrome at Clinical Trials.gov

Trial results on Blau syndrome

Clinical Trials on Blau syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Blau syndrome

NICE Guidance on Blau syndrome

NHS PRODIGY Guidance

FDA on Blau syndrome

CDC on Blau syndrome

Books

Books on Blau syndrome

News

Blau syndrome in the news

Be alerted to news on Blau syndrome

News trends on Blau syndrome

Commentary

Blogs on Blau syndrome

Definitions

Definitions of Blau syndrome

Patient Resources / Community

Patient resources on Blau syndrome

Discussion groups on Blau syndrome

Patient Handouts on Blau syndrome

Directions to Hospitals Treating Blau syndrome

Risk calculators and risk factors for Blau syndrome

Healthcare Provider Resources

Symptoms of Blau syndrome

Causes & Risk Factors for Blau syndrome

Diagnostic studies for Blau syndrome

Treatment of Blau syndrome

Continuing Medical Education (CME)

CME Programs on Blau syndrome

International

Blau syndrome en Espanol

Blau syndrome en Francais

Business

Blau syndrome in the Marketplace

Patents on Blau syndrome

Experimental / Informatics

List of terms related to Blau syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Synonyms and keywords: Pediatric Granulomatous Arthritis (PGA), Juvenile Systemic Granulomatosis, Early Onset Sarcoidosis, Jabs Syndrome, NOD2-associated disease-Blau

Coarse facial features in a boy with Blau syndrome, Image courtesy of Donald A Glass II MD, PhD, Jennifer Maender MD, Denise Metry M

Overview

Blau syndrome is characterized by familial granulomatous arthritis, iritis, and skin granulomas, comprising an autosomal dominantly inherited syndrome that overlaps both sarcoidosis and granuloma annulare.[1]:983[2]:149 Restated, Blau syndrome is a rare autosomal dominant disorder characterized by granulomatous polyarthritis, panuveitis, cranial neuropathies and exanthema.[3]:232

Historical Perspective

Classification

  • There is no established system for the classification of Blau syndrome.

Pathophysiology

  • The exact pathogenesis of Blau syndrome is not fully understood. However, it is caused by a mutation in the NOD2 gene.
  • The disease is inherited in an autosomal dominant mode.
  • This gene encodes a protein called xxxx, involving in the ....
  • NOD2 mutation leads to overactivation of xxxxx which may trigger an exaggerated inflammatory response.

Causes

  • Blau syndrome may be caused by a mutation in the NOD2 gene.

Differentiating Blau syndrome from Other Diseases

Epidemiology and Demographics

  • There is no available data on the prevalence and incidence of Blau syndrome.
  • Blau syndrome commonly affects individuals younger than 4 years of age.
  • There is no racial predilection to Blau syndrome.
  • Blau syndrome affects men and women equally.

Risk Factors

Screening

There is insufficient evidence to recommend routine screening for Blau syndrome.

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

The diagnosis of Blau syndrome is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].

OR

The diagnosis of [disease name] is based on the [criteria name] criteria, which include [criterion 1], [criterion 2], and [criterion 3].

OR

The diagnosis of [disease name] is based on the [definition name] definition, which includes [criterion 1], [criterion 2], and [criterion 3].

OR

There are no established criteria for the diagnosis of Blau syndrome.

History and Symptoms

Physical Examination

Multiple, reddish-brown papules coalescing over the right arm in a boy with Blau syndrome, Image courtesy of Donald A Glass II MD, PhD, Jennifer Maender MD, Denise Metry M

Laboratory Findings

Electrocardiogram

  • There are no ECG findings associated with Blau syndrome.

X-ray

  • There are no x-ray findings associated with Blau syndrome.

Echocardiography or Ultrasound

CT scan

  • There are no CT scan findings associated with Blau syndrome.

MRI

  • There are no MRI findings associated with Blau syndrome.

Other Imaging Findings

  • There are no other imaging findings associated with Blau syndrome.

Other Diagnostic Studies

  • There are no other diagnostic studies associated with Blau syndrome.

Treatment

Medical Therapy

  • There is no treatment for Blau syndrome; the mainstay of therapy is supportive care.

Surgery

  • Surgical intervention is not recommended for the management of Blau syndrome.

Primary Prevention

  • There are no established measures for the primary prevention of Blau syndrome.

Secondary Prevention

  • There are no established measures for the secondary prevention of Blau syndrome.

References

  1. Freedberg, et. al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). McGraw-Hill. ISBN 0071380760.
  2. James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
  3. Ferrero-Miliani L, Nielsen OH, Andersen PS, Girardin SE (2007). "Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation". Clin. Exp. Immunol. 147 (2): 227–35. doi:10.1111/j.1365-2249.2006.03261.x. PMC 1810472. PMID 17223962. Unknown parameter |month= ignored (help)
  4. Blau, Edward B. (1985). "Familial granulomatous arthritis, iritis, and rash". The Journal of Pediatrics. 107 (5): 689–693. doi:10.1016/S0022-3476(85)80394-2. ISSN 0022-3476.
  5. Jabs, Douglas A.; Houk, J.Lawrence; Bias, Wilma B.; Arnett, Frank C. (1985). "Familial granulomatous synovitis, uveitis, and cranial neuropathies". The American Journal of Medicine. 78 (5): 801–804. doi:10.1016/0002-9343(85)90286-4. ISSN 0002-9343.
  6. Rosé, Carlos D.; Aróstegui, Juan I.; Martin, Tammy M.; Espada, Graciela; Scalzi, Lisabeth; Yagüe, Jordi; Rosenbaum, James T.; Modesto, Consuelo; Cristina Arnal, Maria; Merino, Rosa; García-Consuegra, Julia; Carballo Silva, María Antonia; Wouters, Carine H. (2009). "NOD2-Associated pediatric granulomatous arthritis, an expanding phenotype: Study of an international registry and a national cohort in spain". Arthritis & Rheumatism. 60 (6): 1797–1803. doi:10.1002/art.24533. ISSN 0004-3591.

de:Blau-Syndrom